Innovent Biologics Technology Limited (shanghai R&d Center)

This early-phase trial tests a new drug called IBI3026 in 300 adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and check for side effects. Researchers will also monitor how the drug affects tumor growth and…

This study tests a new gout drug, tigulixostat, against an existing one, febuxostat, in 600 Chinese adults with gout. The goal is to see which better lowers uric acid levels below a target threshold over 24 weeks, while also monitoring safety, gout attacks, and quality of life fo…

This study tests a new medicine called IBI302, given as an eye injection, for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if it can prevent vision from getting worse over one year. About 800 adults aged 50 and older w…

This early-phase study is testing a new drug called IBI3032 to see if it is safe and how the body processes it. The study has two parts: one in healthy volunteers and another in people who are overweight or have obesity. The goal is to gather initial safety data before moving to …